Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PMS1 protein homolog 1 (PMS1) is a key component of the eukaryotic DNA mismatch repair (MMR) system, which is responsible for maintaining genomic integrity by correcting base-base mismatches and insertion-deletion loops that occur during DNA replication. PMS1 forms a heterodimer with MLH1 to create the MutL-beta complex, which interacts with other MMR proteins to facilitate DNA repair. While germline mutations in PMS1 are historically associated with hereditary non-polyposis colorectal cancer (HNPCC, also known as Lynch syndrome) due to mismatch repair deficiency and microsatellite instability, PMS1 has recently emerged as a highly promising therapeutic target for Huntington's disease (HD) and other repeat expansion disorders. In these neurological conditions, PMS1 acts as a genetic modifier that drives the continuous somatic expansion of CAG repeats in the HTT gene within vulnerable neurons, accelerating disease onset and progression. Consequently, therapeutic strategies targeting PMS1 aim to reduce its expression using small-molecule RNA splicing modulators, such as SKY-0515 and RGT-0474060, to halt somatic CAG expansion and slow neurodegeneration. However, because PMS1 is essential for DNA repair, a major safety concern and therapeutic challenge of long-term PMS1 inhibition is the potential induction of genomic instability and an increased risk of oncogenesis.
Small molecule RNA splicing modulation to reduce PMS1 mRNA and protein expression
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PMS1 protein homolog 1 (PMS1).